Kenji Hashimoto

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade

Robert J. Motzer, Romain Banchereau, Habib Hamidi et al. · Cancer Cell · 2020 · 520 citations · Full text

Urology, Genitourinary Cancer, Cancer Genomics +8

High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade

Kobe Yuen, Lifen Liu, Vinita Gupta et al. · Nature Medicine · 2020 · 423 citations · Full text

Inflammation, Cancer Immunosurveillance, Reduced Clinical Benefit +12

CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy

Mahrukh Huseni, Lifen Wang, Joanna E. Klementowicz et al. · Cell Reports Medicine · 2023 · 171 citations · Full text

Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer

Yuko Tanabe, Kenji Hashimoto, Chikako Shimizu et al. · International Journal of Clinical Oncology · 2011 · 156 citations

Breast Oncology, Oncology, Pharmacology +6

Tumor-infiltrating lymphocytes, particularly the balance between CD8+ T cells and CCR4+ regulatory T cells, affect the survival of patients with oral squamous cell carcinoma

Yoshiko Watanabe, Fuminori Katou, Haruo Ohtani et al. · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · 2010 · 153 citations

Cancer Immunosurveillance, Medicine, T-regulatory Cell +9